Scleroderma Clinical Trials

28 recruiting

Scleroderma Trials at a Glance

41 actively recruiting trials for scleroderma are listed on ClinicalTrialsFinder across 6 cities in 32 countries. The largest study group is Not Applicable with 8 trials, with the heaviest enrollment activity in Ann Arbor, New York, and Chicago. Lead sponsors running scleroderma studies include Hacettepe University, Firat University, and University Hospital, Bordeaux.

Browse scleroderma trials by phase

Treatments under study

About Scleroderma Clinical Trials

Looking for clinical trials for Scleroderma? There are currently 28 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Scleroderma trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Scleroderma clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 41 trials

Recruiting
Phase 1

Efficacy and Safety of HN2301 in Autoimmune Diseases(AIDs)

Rheumatoid ArthritisSclerodermaSystemic Lupus Erythematosus
Shenzhen MagicRNA Biotechnology Co., Ltd30 enrolled1 locationNCT06801119
Recruiting
Phase 1Phase 2

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

SclerodermaSystemic Sclerosis
Cabaletta Bio12 enrolled10 locationsNCT06328777
Recruiting

Trichoscopy and Systemic Scleroderma

Scleroderma, Systemic
University Hospital, Lille200 enrolled1 locationNCT04804930
Recruiting
Phase 1

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmRheumatoid Arthritis+11 more
National Cancer Institute (NCI)300 enrolled52 locationsNCT03816345
Recruiting
Early Phase 1

TBI Using IMRT and Cyclophosphamide Prior to Stem Cell Transplant for the Treatment of Severe Systemic Sclerosis

Systemic Scleroderma
City of Hope Medical Center15 enrolled1 locationNCT04380831
Recruiting

Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases

Inflammatory Bowel DiseasesSclerodermaVasculitis+2 more
University Hospital, Toulouse3,000 enrolled1 locationNCT05251415
Recruiting
Not Applicable

Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases

SclerodermaMyasthenia Gravis (MG)System Lupus Erythematosus(SLE)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology12 enrolled1 locationNCT07470151
Recruiting
Phase 2

Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis

Scleroderma, Diffuse
Novartis Pharmaceuticals96 enrolled80 locationsNCT06655896
Recruiting

Rheumatology Patient Registry and Biorepository

Rheumatoid ArthritisLyme DiseaseSarcoidosis+17 more
Yale University5,000 enrolled1 locationNCT04402086
Recruiting
Phase 2

Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)

SclerodermaSystemic Sclerosis (SSc)
Zura Bio Inc80 enrolled51 locationsNCT06843239
Recruiting
Phase 2

Platform Clinical Study for Conquering Scleroderma

SclerodermaInterstitial Lung Disease Due to Systemic Disease
Scleroderma Research Foundation, Inc.400 enrolled34 locationsNCT06195072
Recruiting

Transcriptomic Study of Cutaneous Fibroblasts in Scleroderma

Scleroderma
Centre Hospitalier Universitaire Dijon60 enrolled1 locationNCT07256418
Recruiting
Not Applicable

Diffuse Cutaneous Scleroderma (DSSc) SFDI Study

Systemic SclerodermaDiffuse Cutaneous Scleroderma
Boston University65 enrolled1 locationNCT07090226
Recruiting
Phase 2Phase 3

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Scleroderma, SystemicSystemic Sclerosis Associated Interstitial Lung Disease
GlaxoSmithKline300 enrolled131 locationsNCT05878717
Recruiting

Western Sweden Systemic Sclerosis Project

Fibrosis LungScleroderma, SystemicInterstitial Lung Disease Due to Systemic Disease+1 more
Sahlgrenska University Hospital150 enrolled1 locationNCT07345052
Recruiting

Familial Systemic Scleroderma

Systemic Scleroderma
University Hospital, Strasbourg, France20 enrolled1 locationNCT07343115
Recruiting

Maternal Autoimmune Disease Research Alliance (MADRA) Registry

Rheumatoid ArthritisSclerodermaSystemic Lupus Erythematosus+4 more
Duke University1,000 enrolled1 locationNCT03276923
Recruiting
Not Applicable

Investigating the Effectiveness of the Biopsychosocial Model-Based Exercise Approach in Children and Adults Diagnosed With Scleroderma

SclerodermaScleroderma, Localized
Hacettepe University48 enrolled1 locationNCT07292961
Recruiting
Not Applicable

Study of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis

Scleroderma, SystemicDigital Ulcer
Primus Pharmaceuticals45 enrolled5 locationsNCT06256575
Recruiting

A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease

Celiac DiseaseMultiple SclerosisAnkylosing Spondylitis+6 more
TScan Therapeutics, Inc.300 enrolled12 locationsNCT06587828